Doctor profile · Federal record
Dr. STEPHANIE STOCKTON
Psychiatric/Mental Health Nurse Practitioner (CMS: NURSE PRACTITIONER) · WICHITA FALLS, TX
- NPI 1104458108
- Accepts Medicare
- 7 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
4619 SHADY LN
WICHITA FALLS, TX 763091018
(214) 697-5420
Credentials & registration
- NPI registered
- February 2020 — 6 yrs on file
- Profile last updated
- September 14, 2025
- Year of graduation
- 2019 — 7 yrs since
- Specialty taxonomy
- 363LP0808X — NUCC code
- State license (1)
- Texas #AP144293
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1104458108. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
129
Distinct HCPCS
3
Medicare allowed
$8,898
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
90833 |
Psychotherapy with evaluation and management visit, 30 minutes | 73 | 21 | $56 | |
99308 |
Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | 41 | 11 | $62 | |
99306 |
Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 15 | 15 | $151 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 67. This provider delivers 1.9× the peer median.Open Payments
Industry payments received
All-time total
$1,104
Transactions
70
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $220.46 | |
| Neurocrine Biosciences, Inc. | 16 | $192.34 | |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $178.27 | |
| Lundbeck LLC | 5 | $78.57 | |
| Alkermes, Inc. | 4 | $75.42 | |
| ABBVIE INC. | 3 | $68.36 | |
| Corium, LLC | 2 | $56.95 | |
| Axsome Therapeutics, Inc. | 2 | $41.96 | |
| Indivior Inc. | 2 | $39.00 | |
| Teva Pharmaceuticals USA, Inc. | 2 | $34.15 | |
| Lilly USA, LLC | 2 | $33.75 | |
| Tris Pharma Inc | 1 | $25.43 | |
| Almatica Pharma LLC | 1 | $23.89 | |
| IRONSHORE PHARMACEUTICALS INC. | 1 | $18.22 | |
| IDORSIA PHARMACEUTICALS US INC | 1 | $17.32 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
202
Patients
0
Total drug cost
$4,396
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Buspirone Hcl | Generic | 36 | 0 | $347 |
| Fluoxetine Hcl | Generic | 35 | 0 | $467 |
| Quetiapine Fumarate | Generic | 32 | 0 | $816 |
| Divalproex Sodium | Generic | 29 | 0 | $903 |
| Citalopram Hbr (Citalopram Hydrobromide) | Brand | 20 | 0 | $165 |
| Trazodone Hcl | Generic | 20 | 0 | $341 |
| Olanzapine | Generic | 16 | 0 | $846 |
| Duloxetine Hcl | Generic | 14 | 0 | $511 |